Alexander Henry Todd

Title: Alexander Henry Todd: Innovator in Morpholine Derivatives

Introduction

Alexander Henry Todd is a notable inventor based in Macclesfield, GB. He is recognized for his contributions to the field of pharmaceuticals, particularly in the development of morpholine derivatives with antidepressant properties. His work has significant implications for the treatment of depression in warm-blooded animals, including humans.

Latest Patents

Todd holds a patent for "Morpholine derivatives," which relates to new 2-aryloxymethylmorpholine derivatives. These derivatives possess antidepressant properties and include processes for their manufacture. The patent also covers pharmaceutical compositions containing these derivatives and methods for preventing or relieving depression. A typical example of the morpholine derivatives disclosed is 2-(o-ethoxyphenoxymethyl)morpholine. He has 1 patent to his name.

Career Highlights

Todd has made significant strides in his career, working with Imperial Chemical Industries Limited. His research and innovations have contributed to advancements in pharmaceutical chemistry, particularly in the area of mental health treatment.

Collaborations

Throughout his career, Todd has collaborated with notable colleagues, including Keith Blakeney Mallion and Ralph W Turner. These collaborations have furthered the development of his innovative work in the field.

Conclusion

Alexander Henry Todd's contributions to the field of pharmaceuticals, particularly through his patent on morpholine derivatives, highlight his role as an important inventor. His work continues to influence the treatment of depression, showcasing the impact of innovation in healthcare.